Cloning and induced pluripotent stem cells (iPSCs) are related as both involve the manipulation of cells for potential medical applications. iPSCs can be generated from adult cells and hold promise for regenerative medicine, allowing for patient-specific treatments. While cloning produces genetically identical organisms, it faces ethical concerns, particularly regarding human experimentation.